PD-L1 expression as a biomarker for nivolumab (NIVO) plus ipilimumab (IPI) and NIVO alone in advanced melanoma (MEL): A pooled analysis Meeting Abstract
| Authors: | Long, G. V.; Larkin, J.; Ascierto, P. A.; Hodi, F. S.; Rutkowski, P.; Sileni, V.; Hassel, J.; Lebbe, C.; Pavlick, A. C.; Wagstaff, J.; Schadendorf, D.; Dummer, R.; Hogg, D.; Haanen, Jbag; Corrie, P.; Hoeller, C.; Horak, C.; Wolchok, J.; Robert, C. |
| Abstract Title: | PD-L1 expression as a biomarker for nivolumab (NIVO) plus ipilimumab (IPI) and NIVO alone in advanced melanoma (MEL): A pooled analysis |
| Meeting Title: | 41st European Society for Medical Oncology Congress (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2016 Oct 7-11 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-10-01 |
| Start Page: | vi381 |
| Language: | English |
| ACCESSION: | WOS:000393913000205 |
| DOI: | 10.1093/annonc/mdw379.07 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1112PD -- Source: Wos |
